Canterbury DHB



The diagnosis of Smouldering Multiple Myeloma (SMM) can be defined by the presence of a monoclonal protein ≥30 g/L or bone marrow plasmacytosis of more than 10%, in the absence of anaemia, hypercalcaemia, lytic bone lesions, and renal failure attributable to a plasma cell proliferation disorder.

About this Canterbury DHB document (5577):

Document Owner:

Amy Holmes (see Who's Who)

Last Reviewed:

September 2014

Next Review:

September 2016


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5577